Pharmacists in Glen Rock, NJ Accepting Medicare
7 Pharmacists found. Showing 1 - 7
 Jayne B Kopacki, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 191 Rock Rd, Glen Rock, NJ 07452 Phone: 201-444-4190 Fax: 201-444-2698 |
Vaidehi Upadhyaya, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 175 Rock Rd, Glen Rock, NJ 07452 Phone: 973-513-2575 |
Mrs. Lisa Miraglia-ranoff, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 191 Rock Rd, Glen Rock, NJ 07452 Phone: 201-444-4190 |
Sofiya Tamarov Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 175 Rock Rd, Glen Rock, NJ 07452 Phone: 201-445-2857 |
 Dr. Vishnu G Patel, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 191 Rock Rd, Glen Rock, NJ 07452 Phone: 973-722-6664 |
Mr. Matthew H Kopacki, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 191 Rock Rd, Glen Rock, NJ 07452 Phone: 201-444-4190 Fax: 201-444-2698 |
Joyce Lam Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 186 Chadwick Pl, Glen Rock, NJ 07452 Phone: 201-669-8362 |
News Archive
Bisphenol A tainted money and receipts
Bisphenol A (BPA) has been found in many household items and other common objects and is known to be an endocrine disruptor linked to infertility, genital abnormalities, cancer and more. Now it has been detected on ‘cash'. Since BPA is used to make plastic, manufacturers use about 8 billion pounds of BPA that is moulded, cooked or poured into toys, baby products and other merchandise each year. On these products BPA is chemically bonded but it is simply applied in a powdery film to paper, making it easy to rub off with a touch.
More flexible approach can improve efficiency of preclinical research, study shows
The translation of preclinical research findings into effective treatments continues to deliver unsatisfactory results.
Altus Pharmaceuticals reaffirms plan to submit NDA for Trizytek
Altus Pharmaceuticals Inc. announced today that it is reaffirming its plan to submit a new drug application (NDA) for Trizytek TM (liprotamase) in the first-half of 2009.
New safety guideline released for prescribing biological therapies in inflammatory arthritis
The British Society for Rheumatology publishes its latest clinical guideline in Rheumatology, the UK's key specialist journal in the sector. The new guideline updates and presents two previous guidelines into one set of evidence based recommendations on the vital safety aspects of prescribing biological therapies in inflammatory arthritis.
› Verified 6 days ago
Counselors
Dentists
Psychologists
Occupational Therapists
Clinical Social Workers
Pharmacists
Marriage Counselors